Recruiting
Phase 1

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Sponsor:

Mayo Clinic

Code:

NCT04007744

Conditions

Clinical Stage III Cutaneous Melanoma AJCC v8

Clinical Stage III Gastric Cancer AJCC v8

Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IV Cutaneous Melanoma AJCC v8

Clinical Stage IV Gastric Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Pembrolizumab

Sonidegib

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information